PH14332A - 4-hydroxyphenylalkanolamine derivatives - Google Patents

4-hydroxyphenylalkanolamine derivatives

Info

Publication number
PH14332A
PH14332A PH21221A PH21221A PH14332A PH 14332 A PH14332 A PH 14332A PH 21221 A PH21221 A PH 21221A PH 21221 A PH21221 A PH 21221A PH 14332 A PH14332 A PH 14332A
Authority
PH
Philippines
Prior art keywords
hydroxyphenylalkanolamine
derivatives
hydroxyphenylalkanolamine derivatives
Prior art date
Application number
PH21221A
Inventor
R Philion
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of PH14332A publication Critical patent/PH14332A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/62Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH21221A 1976-06-25 1978-05-31 4-hydroxyphenylalkanolamine derivatives PH14332A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69985676A 1976-06-25 1976-06-25
US80337277A 1977-06-03 1977-06-03

Publications (1)

Publication Number Publication Date
PH14332A true PH14332A (en) 1981-05-29

Family

ID=27106508

Family Applications (2)

Application Number Title Priority Date Filing Date
PH19910A PH15041A (en) 1976-06-25 1977-06-24 4-hydroxyphenylalkanolamine derivatives
PH21221A PH14332A (en) 1976-06-25 1978-05-31 4-hydroxyphenylalkanolamine derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PH19910A PH15041A (en) 1976-06-25 1977-06-24 4-hydroxyphenylalkanolamine derivatives

Country Status (21)

Country Link
JP (1) JPS5321134A (en)
AR (2) AR220896A1 (en)
AT (1) AT354420B (en)
AU (1) AU512626B2 (en)
CA (1) CA1091245A (en)
CH (2) CH627447A5 (en)
DE (1) DE2728641A1 (en)
DK (1) DK146386C (en)
ES (1) ES460040A1 (en)
FI (1) FI771976A (en)
FR (1) FR2366272A1 (en)
GB (1) GB1544872A (en)
HK (1) HK60184A (en)
IE (1) IE45631B1 (en)
IL (1) IL52353A (en)
LU (1) LU77604A1 (en)
NL (1) NL7707128A (en)
NO (1) NO144848C (en)
PH (2) PH15041A (en)
PT (1) PT66713B (en)
SE (1) SE7707341L (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4410548A (en) 1980-07-09 1983-10-18 Reckitt & Colman Products Limited Propanolamine derivatives
DE3128117A1 (en) * 1980-07-29 1982-03-11 Yamanouchi Pharmaceutical Co., Ltd., Tokyo NEW PHENYL-AETHYLAMINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF
AU620573B2 (en) * 1987-11-27 1992-02-20 Societe Nationale Elf Aquitaine Process for phenol alkylthiolation and its application to the synthesis of 4-acyl-2-alkylthiophenols
FR2623804B1 (en) * 1987-11-27 1990-03-23 Elf Aquitaine PHENOL ACYLATION
US5101065A (en) * 1991-02-04 1992-03-31 Imperial Chemical Industries Plc Acetophenone intermediates
EP0692266B1 (en) 1991-08-21 2000-03-22 Smith & Nephew, Inc. Fluid management system
JP2002501018A (en) 1998-01-26 2002-01-15 マイトコー Mitochondrial protective agents for treating mitochondrial-related diseases
EP1138666B1 (en) * 2000-03-28 2004-03-03 Council of Scientific and Industrial Research A preparation method for 4-(P-methoxyphenyl)-2-amino-butane and an insecticidal composition comprising it
CN1681495B (en) 2002-08-19 2010-05-12 辉瑞产品公司 Combination therapy for hyperplasia diseases
GT200600381A (en) 2005-08-25 2007-03-28 ORGANIC COMPOUNDS
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101663262B (en) 2006-12-01 2014-03-26 百时美施贵宝公司 N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
CN102428061B (en) * 2009-05-19 2015-09-30 本州化学工业株式会社 The manufacture method of triphen phenols and monoesters substituent thereof and 4-acyl group aralkylphenol derivative
WO2014170786A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN104324977A (en) * 2014-10-22 2015-02-04 无锡市得力手机械有限公司 Wire unloading trolley of inverted wire drawing machine
HU231124B1 (en) * 2016-02-10 2020-12-28 Egis Gyógyszergyár Zrt. Method for producing morphologically homogenous mirabegron and mirabegron monohydrochloride
CN113574055A (en) 2019-01-18 2021-10-29 阿斯利康(瑞典)有限公司 PCSK9 inhibitors and methods of use thereof

Also Published As

Publication number Publication date
PH15041A (en) 1982-05-20
AU2636877A (en) 1979-01-04
HK60184A (en) 1984-08-10
ATA449377A (en) 1979-06-15
FR2366272A1 (en) 1978-04-28
AR220896A1 (en) 1980-12-15
FR2366272B1 (en) 1981-03-06
JPS5321134A (en) 1978-02-27
CA1091245A (en) 1980-12-09
AT354420B (en) 1979-01-10
DE2728641A1 (en) 1978-01-05
IE45631L (en) 1977-12-25
AU512626B2 (en) 1980-10-23
DK146386B (en) 1983-09-26
NL7707128A (en) 1977-12-28
AR227126A1 (en) 1982-09-30
PT66713B (en) 1978-11-21
IL52353A0 (en) 1977-08-31
IL52353A (en) 1981-07-31
DK281777A (en) 1977-12-26
CH630068A5 (en) 1982-05-28
SE7707341L (en) 1978-02-13
NO144848B (en) 1981-08-17
ES460040A1 (en) 1978-05-01
PT66713A (en) 1977-07-01
IE45631B1 (en) 1982-10-20
CH627447A5 (en) 1982-01-15
FI771976A (en) 1977-12-26
NO772245L (en) 1977-12-28
NO144848C (en) 1981-11-25
GB1544872A (en) 1979-04-25
DK146386C (en) 1984-03-12
LU77604A1 (en) 1978-02-01

Similar Documents

Publication Publication Date Title
PH14332A (en) 4-hydroxyphenylalkanolamine derivatives
GB1541547A (en) 4-phenoxymethylpiperidine derivatives
IL52002A0 (en) M-phenoxybenzamide derivatives
GB1521020A (en) 4-hydrox-aporphine derivatives
AU2222977A (en) Tetrahydro-echinocandin b derivatives
GB1543124A (en) 2-iminothiazolidine derivatives
GB1554517A (en) Nogarol derivatives
PT66360A (en) Nicotinoylaminotriazine derivatives
JPS52105138A (en) Novellphenyll22aminoethanol derivatives
GB1553759A (en) Tetrahyddropyridine derivatives
GB1523198A (en) Thiazolo-rifamycin derivatives
GB1549755A (en) N-4-halobutyryl derivatives
IL52270A0 (en) Hydrazinopyridazine derivatives
GB1524481A (en) Tetrahydo - imidazopyridine derivatives
GB1545021A (en) 5-norbicyclomycin derivatives
JPS52100431A (en) Anilinoacetate derivatives
JPS532487A (en) Quinoxalinee1*44dioxide derivatives
JPS5297915A (en) Alkylaminoglucopyranoside derivatives
AU2536577A (en) 2-nitroindandione derivatives
PH13411A (en) 8-adnantylaninometryl ergolene derivatives
GB1535080A (en) Naphthacenequinone derivatives
JPS52105159A (en) Estrogene derivatives
GB1544289A (en) Thiazolinotriazine derivatives
JPS5283696A (en) Cephalospoline derivatives
JPS5283495A (en) Thienothiazine derivatives